RVVTF·761516103·US·Common Stock·Healthcare - Drug Manufacturers - Specialty & Generic
RVVTF (Revive Therapeutics Ltd.) is held by 0 institutional investors as of Q4 2024.
No signal yet — fewer than 2 funds hold RVVTF.
Data sourced from four SEC data sources: 13F, Form 4, 13D/13G, and STOCK Act. Not financial advice. Full disclaimer